Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›
Research›
Non-Profits›
Phase Biolabs
AddedMar 20, 2024
UpdatedJul 7, 2026
Phase Biolabs

Phase Biolabs

Operating

Phase Biolabs: Creating carbon-negative chemicals and fuels via fermentation.

Founded
2020
Location
Nottingham, Nottinghamshire, GB
Overview
Compare
Employees
Website

Founded with a mission to combat climate change, Phase Biolabs focuses on creating carbon-negative chemicals and fuels from carbon dioxide (CO2) using innovative fermentation processes. Their core vision is to transform industrial CO2 emissions into valuable products, thus reducing the carbon footprint. The company specializes in producing carbon-negative solvents and electro-fuels, targeting industries looking to adopt sustainable practices and reduce their environmental impact.

Phase Biolabs has garnered support from notable figures and organizations, including Bill Gates' Breakthrough Energy Foundation through their Innovator Fellowship program. This backing underscores the company's potential and credibility in the field of sustainable technology. Key achievements include developing proprietary fermentation technology that efficiently converts CO2 into useful chemicals, positioning Phase Biolabs as a pioneer in the green chemistry market. Their work contributes significantly to the global effort to mitigate climate change by offering scalable, eco-friendly alternatives to traditional chemical production methods.

Phase Biolabs - Similar Organizations

Carbix logo

Carbix

carbixcorp.com

RenewCO2 logo

RenewCO2

renewco2.com

Genecis Bio logo

Genecis Bio

genecis.co

WasteFuel logo

WasteFuel

wastefuel.com

Carba logo

Carba

carba.com

Mycocycle logo

Mycocycle

mycocycle.com

Hago Energetics logo

Hago Energetics

hagoenergetics.com

Alder Fuels logo

Alder Fuels

Biosorra logo

Biosorra

biosorra.com

Ephemrial logo

Ephemrial

ephemrial.com

Phase Biolabs - Quick Facts

What organizations are similar to Phase Biolabs?

Organizations similar to Phase Biolabs include Carbix, RenewCO2, Genecis Bio and WasteFuel.

When was Phase Biolabs founded?

Phase Biolabs was founded in 2020.

Where is Phase Biolabs' headquarters located?

Phase Biolabs' headquarters is located in Nottingham, Nottinghamshire, GB.

When was Phase Biolabs' last funding round?

Phase Biolabs' most recent funding round was for $500k (USD) in March 2022.

How much has Phase Biolabs raised to-date?

As of Mar 29, 2022, Phase Biolabs has raised a total of $500k (USD).

How many employees does Phase Biolabs have?

Phase Biolabs has 8 employees as of Feb 24, 2024.

Phase Biolabs - Classification

Ownership
  • Venture Capital
Technology
  • Fermentation
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Chemicals
  • Fuels
Tags
  • Biotech
  • Cleantech
NAICS
  • 813000Religious, Grantmaking, Civic, Professional, and Similar Organizations
  • 813300Social Advocacy Organizations
  • 813310Social Advocacy Organizations
  • 813312Environment, Conservation and Wildlife Organizations
  • 810000Other Services (except Public Administration)
SIC
  • 4900Electric, Gas, And Sanitary Services
  • 4950Sanitary Services
  • 4952Sewerage Systems
Show 11 more industry codes
NAICS
  • 220000Utilities
  • 221000Utilities
  • 221300Water, Sewage and Other Systems
  • 221320Sewage Treatment Facilities
  • 423000Merchant Wholesalers, Durable Goods
  • 423900Miscellaneous Durable Goods Merchant Wholesalers
  • 423930Recyclable Material Merchant Wholesalers
  • 420000Wholesale Trade
SIC
  • 8390Social Services, Not Elsewhere Classified
  • 8300Social Services
  • 8399Social Services, Not Elsewhere Classified